Patients who present with chronic rhinosinusitis with nasal polyps typically undergo surgery or are given steroids to eliminate polyps. Anthony Del Signore, MD, PharmD, is investigating the use of tezepelumab—typically used to treat severe asthma and allergies—to shrink the polyps, thus reducing the need for surgery.